Global Med Technologies(R), Inc. Licenses SafeTrace Tx(R) Transfusion Management System to Dameron Hospital
January 26 2006 - 9:30AM
PR Newswire (US)
- Wyndgate's Alliance With Siemens Continues to Thrive - DENVER,
Jan. 26 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a
division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) announced today that Dameron Hospital has purchased
the SafeTrace Tx(R)* advanced transfusion management system. Terms
of the agreements were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) The
purchase agreement between Wyndgate and Dameron Hospital was
developed in close collaboration with Siemens Medical Solutions.
With this most recent venture, Wyndgate and Siemens continue to
strengthen their ongoing relationship and bring further benefits to
their mutual customers. "There were many considerations in choosing
to replace our existing transfusion service system with Wyndgate's
SafeTrace Tx information system," commented Richard L. Wong CLS, MT
(ASCP), Administrative Director of the Clinical Laboratory at
Dameron. Mr. Wong continued, "One key consideration was that the
system is integrated with Siemens NOVIUS(R) Lab. Another
consideration particular to SafeTrace Tx was its
Patient-At-A-Glance Bar(TM) safety feature, which displays special
transfusion requirements, antibodies, history of transfusion
reactions, and the availability of current specimens or autologous
donations. Another factor in our decision was Wyndgate's support of
'point-of-care' positive patient identifications systems." Wm.
Scott Dustin, Vice President of Sales and Marketing for Wyndgate
Technologies, said, "Dameron Hospital is committed to high
standards for technological superiority and provides its community
with quality, advanced healthcare. Wyndgate is pleased that its
SafeTrace Tx system will be supporting Dameron's staff as they
uphold these values." Mr. Dustin also stated, "Our relationship
with Siemens continues to grow and prosper. We value all of our
partnerships and the benefits they deliver to our customers. We
look forward to further collaborations with Siemens in 2006." About
Dameron Hospital Dameron Hospital is a fully accredited hospital
offering a broad range of medical, surgical, and health maintenance
services for emergency and acute care. Both not-for-profit and
non-sectarian, Dameron Hospital exists solely to serve the
healthcare needs of the community of Stockton, providing its
neighbors with advanced technology and state-of-the-art diagnostic
and therapeutic equipment -- as well as facilities for inpatient,
outpatient and occupational patient care. About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx(R) advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending First Call Analyst: FCMN
Contact: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or Mike
Graff, both of The Investor Relations Group, +1-212-825-3210, for
Global Med Technologies, Inc. Web site: http://www.peoplemed.com/
Web site: http://www.wyndgate.com/ http://www.globalmedtech.com/
Copyright